DOPAMINE RECEPTOR SUBTYPES - BEYOND THE D1/D2 CLASSIFICATION

被引:256
作者
ANDERSEN, PH
GINGRICH, JA
BATES, MD
DEARRY, A
FALARDEAU, P
SENOGLES, SE
CARON, MG
机构
[1] DUKE UNIV,MED CTR,DEPT CELL BIOL,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT OPHTHALMOL,DURHAM,NC 27710
[3] UNIV TENNESSEE,CTR HLTH SCI,DEPT BIOCHEM,MEMPHIS,TN 38163
关键词
D O I
10.1016/0165-6147(90)90249-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The D1/D2 dopamine receptor classification is widely accepted. However, intense investigative efforts over the last several years using pharmacological, biochemical and behavioral approaches have produced results that are increasingly difficult to reconcile with the existence of only two dopamine receptor subtypes. Recent developments, including cloning of the cDNAs and/ or genes for several members of the large family of G-protein-coupled receptors, have revealed that heterogeneity in the pharmacological or biochemical characteristics of individual receptors often indicates the presence of previously unsuspected molecular subtypes. In this article, Marc Caron and colleagues have assembled the main lines of evidence that suggest the presence of several novel subtypes for both D1 and D2 dopamine receptors and predict that molecular cloning will, in the near future, confirm their existence. © 1990.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 45 条
[1]  
ALBERT PR, 1990, J BIOL CHEM, V265, P2098
[2]   EVIDENCE FOR DIFFERENT STATES OF THE DOPAMINE D1 RECEPTOR - CLOZAPINE AND FLUPERLAPINE MAY PREFERENTIALLY LABEL AN ADENYLATE CYCLASE-COUPLED STATE OF THE D1-RECEPTOR [J].
ANDERSEN, PH ;
BRAESTRUP, C .
JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) :1822-1831
[3]  
ANDERSEN PH, 1988, SOC NEUR ABSTR
[4]   INACTIVATION OF DOPAMINE D-1 OR D-2 RECEPTORS DIFFERENTIALLY INHIBITS STEREOTYPIES INDUCED BY DOPAMINE AGONISTS IN RATS [J].
ARNT, J ;
HYTTEL, J ;
MEIER, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (1-2) :37-47
[5]   PRESENCE OF DOPAMINE-DEPENDENT ADENYLATE-CYCLASE ACTIVITY IN HUMAN RENAL CORTEX [J].
BALDI, E ;
PUPILLI, C ;
AMENTA, F ;
MANNELLI, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 149 (03) :351-356
[6]  
BISCHOFF S, 1981, EUR J PHARMACOL, V79, P225
[7]   2ND MESSENGERS ASSOCIATED WITH THE ACTION OF AII AND DOPAMINE-D2 RECEPTORS IN ANTERIOR-PITUITARY - RELATIONSHIP WITH PROLACTIN SECRETION [J].
BOCKAERT, J ;
JOURNOT, L ;
ENJALBERT, A .
JOURNAL OF RECEPTOR RESEARCH, 1988, 8 (1-4) :225-243
[8]   CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA [J].
BUNZOW, JR ;
VANTOL, HHM ;
GRANDY, DK ;
ALBERT, P ;
SALON, J ;
CHRISTIE, MJ ;
MACHIDA, CA ;
NEVE, KA ;
CIVELLI, O .
NATURE, 1988, 336 (6201) :783-787
[9]   ALKYLATION OF STRIATAL DOPAMINE-RECEPTORS ABOLISHES STEREOTYPED BEHAVIOR BUT HAS NO EFFECT ON DOPAMINE STIMULATED ADENYLATE-CYCLASE ACTIVITY [J].
CAMERON, DL ;
CROCKER, AD .
NEUROSCIENCE LETTERS, 1988, 90 (1-2) :165-171
[10]   THE INHIBITION OF PHOSPHATIDYLINOSITOL TURNOVER - A POSSIBLE POSTRECEPTOR MECHANISM FOR THE PROLACTIN SECRETION-INHIBITING EFFECT OF DOPAMINE [J].
CANONICO, PL ;
VALDENEGRO, CA ;
MACLEOD, RM .
ENDOCRINOLOGY, 1983, 113 (01) :7-14